Evidence map›Paper›PMID 34567248›Full record

ArticleEcancermedicalscience2021

Impact of the coronavirus disease pandemic on cancer care in Croatia: a multicentre cross-sectional study.

Renata Kelemenic-Drazin, Anuska Budisavljevic, Natalija Dedic Plavetic, Iva Kardum Fucak, Tajana Silovski, Vesna Telesmanic Dobric, Mario Nalbani, Zvonimir Curic, Zvjezdana Boric-Mikez, Tatjana Ladenhauser and 4 more

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Renata Kelemenic-DrazinDepartment of Haematology, Oncology and Clinical Immunology, General Hospital Varazdin, I. Mestrovica 1, 42000, Varazdin, Croatia.
Anuska BudisavljevicDepartment of Haematology and Oncology, General Hospital Pula, Zagrebacka 30, 52100, Pula, Croatia.
Natalija Dedic PlaveticDepartment of Oncology, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
Iva Kardum FucakDepartment of Gastroenterology, Haematology and Oncology, General Hospital Dr. Tomislav Bardek Koprivnica, Ulica doktora Zeljka Selingera bb, 48000, Koprivnica, Croatia.
Tajana SilovskiDepartment of Oncology, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.
Vesna Telesmanic DobricDepartment of Oncology and Nuclear Medicine, General Hospital Zadar, Ul. Boze Pericica 5, 23000, Zadar, Croatia.
Mario NalbaniDepartment of Oncology, General Hospital Dubrovnik, Dr. Roka Misetica 2, 20000, Dubrovnik, Croatia.
Zvonimir CuricDepartment of Oncology, General Hospital Dubrovnik, Dr. Roka Misetica 2, 20000, Dubrovnik, Croatia.
Zvjezdana Boric-MikezDepartment of Haematology and Oncology, General Hospital Dr. Josip Bencevic Slavonski Brod, Ul. Andrije Stampara, 35000, Slavonski Brod, Croatia.
Tatjana LadenhauserDepartment of Oncology, University Hospital Centre Osijek, Ul. Josipa Huttlera 4, 31000, Osijek, Croatia.
Dragan TrivanovicDepartment of Haematology and Oncology, General Hospital Pula, Zagrebacka 30, 52100, Pula, Croatia.
Zeljko VojnovicDepartment of Haematology, Oncology and Clinical Immunology, General Hospital Varazdin, I. Mestrovica 1, 42000, Varazdin, Croatia.
Ilijan TomasDepartment of Oncology, University Hospital Centre Osijek, Ul. Josipa Huttlera 4, 31000, Osijek, Croatia.
Stjepko PlestinaDepartment of Oncology, University Hospital Centre Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe coronavirus disease (COVID-19) pandemic has greatly affected the oncology community worldwide. Lockdowns, an epidemiological measure, have made it difficult for oncologists to provide care. In this study, we analysed the impact of the COVID-19 pandemic on Croatian cancer care.

methodsThis was a multicentre cross-sectional observational study of 422 patients who received systemic oncology therapy during the pandemic. The patients completed a survey to capture their views on the impact of the COVID-19 pandemic on their cancer care. Univariate descriptive and bivariate analyses were performed to analyse the relationship between the patients' perspective on the impact of the COVID-19 pandemic on cancer care and the quality of Croatian cancer care and their clinical and sociodemographic data.

resultsDiscontinuation or change in cancer treatment during the COVID-19 pandemic was observed in 10.2% of cases. Most did not change their place of treatment owing to the lockdown (97.6%). 14.7% of the patients felt that the quality of cancer care received had changed during the pandemic.

conclusionsIn the first few months of the pandemic, Croatia had a favourable epidemiological situation. However, 25% of patients with cancer reported that the pandemic affected cancer treatment and the quality of cancer care.

Indexed as

cancer carecoronavirusCOVID-19pandemicpatients' perspective

Identifiers

PMID34567248
PMCPMC8426007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.